The USA-India Chamber of Commerce mission is to provide a pro-active & professional platform for high ranking policy makers, senior business executives, academicians, and investors in the United States and India to network, facilitate and promote trade, investments & economic cooperation. USAIC’s four point agenda is: Trade, Investment, Policy and Advocacy.
US-India BioPharma & Healthcare Summit, Friday, May 11, 2012
Our annual US-India BioPharma & Healthcare Summit has created an ecosystem bringing together all stakeholders: healthcare and life sciences executives, investors, policy makers and academia. 2011 Summit attracted over 300 senior executives. Annual Summit has become THE BioPharma event in the world to learn and share for senior executives focused on Drug Discovery & Development, Licensing, Clinical Research, External Research, Healthcare, Innovation, M&A, Deal Flow and Emerging Markets. Senior policy makers from India are regular participants.
The Summit helps facilitate B2B collaborative research partnerships, Industry-Academic partnerships, cross border investments, create public-private-academic partnerships and open new opportunities to take the Global BioPharma and Healthcare business to the next level.
HIGHLIGHTS
Annual high profile summit of established and emerging BioPharma, Medical Devices, Healthcare companies, Venture Capitalists, Policy Makers and Academia from the US, Europe and India
Annual R&D spend of just the Advisory Board members in excess of $25 billion
THE Bio Pharma event in the world focused on BioPharma, Medical Devices and Healthcare
Annual summit provides continuity and results by bringing all stakeholders together
Release of USA-India Chamber of Commerce commissioned The Boston Consulting Group Position Paper
Hear about critical trends directly from the global industry thought leaders and policy makers to create your successful R&D and emerging market strategies
Learn about new models in R&D, partnering and commercial models - DIRECTLY from major implementers
Meet & Network with the top global industry thought leaders, investors, academicians and policy makers at one location
Highest concentration of senior level successful global BioPharma executives, R&D leaders, Academicians and VCs
Big participation by leadership of top Medical and Public Health Schools
An ideal platform to Learn Share Network Benefit
A forum open only to senior executives
Networking Tea Breaks, Hosted Lunch, Cocktails & High Power Networking Reception
A limited number of rooms have been held at the conference Room rate of $239 per night exclusive of applicable taxes for May 10 and 11 at Hyatt Regency Cambridge. Rooms are issued on a first come first served basis and are available until April 18, 2012. All reservations must be made individually online at the special Hyatt web site link: or call 888-421-1442. Please tell the operator about the US-India Biopharma Summit Room Block.
PARKING
Validated discounted parking is available for summit participants at Hyatt Regency Cambridge.
Please collect your discount tickets at the time of registration.
DIRECTIONS From the West From Mass Pike: Take exit 18 - Allston / Cambridge (left hand exit).
Follow the signs for Cambridge. Cross the River Street Bridge, exit right at the end of the bridge onto Memorial Drive. Hyatt is 1/2 mile up on Memorial Drive (Route 3) on the left hand side. Turn left at the traffic light to access the hotel entrance and parking garage.
From the South
From I-93: Take exit 26 - Storrow Drive/Back Bay/Cambridge.
Stay in the right lane (Storrow Drive). Go 3/4 mile and take second exit on left, Government Center/Kendall Square. Go up the ramp and stay in the right lane. Turn right at the stop sign; go across the Longfellow Bridge. Take the first right off bridge and turn onto Memorial Drive (Route 3). Stay on Memorial Drive approximately 1 mile on right, at light turn right. Hyatt is on your left.
From the North
From I-93 or Route 1: Take exit 26 - Storrow Drive and follow "FROM THE SOUTH" directions.
From Logan International Airport
Follow signs to the Mass Turnpike: 90 Boston/Williams Tunnel. Pay toll upon exiting airport. You will be heading West on 90. From 90 West, take exit 20 Brighton/Cambridge (pay another toll). Out of the toll booth, bear right following sign for Cambridge/Somerville exit. From this exit ramp, stay straight through two lights and cross over the bridge. Just over the bridge, turn right at the light onto Memorial Drive. Stay in the left lane. Continue up/over overpass keeping in left lane. At the first light on Memorial Drive make a left and then another quick left into the Hyatt front circle.
Participants can register online.
Payment can be made by Credit card Registration fee: $900
Limited seats. Registration fee will go up soon.
No walk-ins or at the door registration.
Summit open only to Senior Executives, Entrepreneurs, Venture Capitalists, Investment Bankers, Private Equity Firms, Academia and Policy makers in the Life Sciences industry (Pharmaceuticals, Biotechnology, Medical Devices and Healthcare). Restricted entry for Service firms, Sales personnel and Consultants. USA-India Chamber of Commerce reserves the right to decline any registration without assigning any reason.
Paul Stoffels, MD, Group Chairman Global Pharma, Johnson & Johnson
I would like to thank you for the exceptional successful meeting yesterday in Cambridge.
Me and my team made a significant number of new contacts. We will start working on all of the follow ups. I look forward to a continued participation in your organization.
Hari S Bhartia, Co - Chairman & Managing Director, Jubilant Life Sciences
For the last five years, I have observed the annual US-India BioPharma & Healthcare Summit play a significant role in forging partnerships between the global BioPharma and Indian companies. USAIC has been able to involve and engage Global BioPharma R&D leaders and key stakeholders to foster innovation. These interactions have led to innovative business ideas, new partnerships and business.
Dr. Mikael Dolsten, President Worldwide R&D, Pfizer
Biopharma and biotech companies have a strong interest in the continued growth of India’s innovative drug research industry – to improve public health in India and the world. Pfizer has a global network of academic alliances and strategic partnerships, including collaborations with several Indian Biopharma companies and CROs, to accelerate our delivery of differentiated medicines. This summit, organized by the USA-India Chamber of Commerce, by connecting companies with high quality drug designers and developers in India, is valuable to the industry and to patients.
Peter Mueller, PhD; Executive Vice President, Vertex Pharmaceuticals
You did a fantastic job!!! It's a pleasure to work with you and see the summit grow year by year!
Dr. Ivan Gergel, Executive Vice President R&D, Endo Pharmaceuticals
I thought that the summit was a great success. Thank you for the opportunity to be a part of it.
Prof. Nirmal K. Ganguly, Chairman JIPMER
Thank you very much for inviting me to attend the US-India BioPharma & Healthcare Summit 2011. It is one of the best which I have ever attended. Please accept my congratulations.
K.V. Subramaniam, President & CEO, Reliance Life Sciences
The innovation-driven ecosystem fostered by the USA-India Chamber of Commerce has led to meaningful research and technology partnerships between global and Indian companies. I have been involved with this platform for the last few years and it is a great feeling to see it evolve as the Summit of Choice for global research and technology leaders and investors..
Debasish Roychowdhury, MD; Chief Oncology Officer, Sanofi
Karun – congratulations on a very good conference. You have the magic touch – getting people together and giving them a safe harbor for open discussions. I was also very fortunate to be in the audience to hear Dr. Bhan. What an inspirational speech – I would love to hear it again and again and get the inspiration.
Davinder Brar, Chairman, GVK Bio Sciences
The Summit was a resounding success and this one event will add much more to the furtherance of US – India business than many of the delegations which are undertaken for the same purpose.
The quality of scientific talent assembled by you was superb and I still wonder how you manage to pull off such a thing !!! It is rare to see heads of global pharma companies come together for a common cause in such large numbers. Overall the setting was excellent, attendance impressive and the quality of discussions very thought provoking. The party was refreshingly energetic till the late evening.
Once again thanks for all your unceasing efforts.
Richard Connell, PhD; Vice President, Pfizer
It was a stimulating event and I think everyone enjoyed the opportunity to discuss and debate new ways to frame and address the key issues of people, productivity, innovation and risk.
Ansbert K. Gadicke, Managing Director, MPM Capital
Thank you for including me. The event was spectacular, I am deeply impressed by what you have been able to put together!
Sri Mosur, CEO GDDD, Jubilant Life Sciences
As Merv Turner, put it, we did entertain the audience as well as educate them on the dynamics of the industry.
Thank you for the opportunity to participate in such a distinguished forum, I truly enjoyed the very open interactions. I look forward to the next meeting as well as personal interactions during the course of our professional endeavors.
Karun, thanks for pulling together a wonderful show.. it can only get better going forward…
Barry Mangum, PharmD, FCP; Director Clinical Pharmacology, Duke Clinical Research
I found the Boston meeting one of the best conferences of my year. Your organizational skill was excellent and found the content most informative.
James Thomas, Co-founder & Partner, Thomas, McNerney & Partners
Thanks to you and your team for an excellent day and evening yesterday. I found the meeting very helpful and enjoyable.
Joshua Berlin, Executive Editor, Elsevier Business Intelligence
We wanted to thank you again for inviting us to participate last week in such a great event. The discussion was of the highest caliber, and gave us much food for thought.
Senior Vice President R&D, Amgen
I wanted to drop you a short note to thank for such a wonderful meeting. The content and networking opportunity were beyond any expectation that I had going into the experience. Over the past several days I have reviewed the Position Paper and think that it is a tremendous contemporary analysis of the business.
Finally, I really appreciated the dinner and all of the toasts that were exchanged with dessert. What a collegial group of professionals!
Dean, Tufts University School of Medicine
I thought the meeting was a great success and I was honored to be part of it. As a result of the meeting, we made some important contacts with both the Indian government and a number of companies. These contacts have the potential to help Tufts achieve several of our objectives.
I very much appreciate all the efforts you have made.
Ramesh Kumar, CEO, Onconova
I greatly benefited from attending this conference. The program was well organized.
Chief of Staff to the President, Pfizer Global R&D
Many thanks Karun. Super summit yesterday. You out did yourself once again this year - it was a fabulous agenda and a lot of super discussions.
Jay Knowles, Head-Platforms, Strategic Alliances, Novartis Institutes of Biomedical Research
Many thanks for inviting me to your conference today.
It was definitely rewarding and gave me great hope for the long-term future of India.
Alpna Seth, PhD; Vice President, Biogen Idec
Just wanted to say congratulations for organizing and executing an outstanding meeting- in every way- content, participants, speakers, logistics, overall set up. Really a great job done by you and your staff.
Santosh Vetticaden, PhD, MD; Chief Medical Officer, Cubist
Kudos on a organizing and conducting very nice Summit. I enjoyed attending the meeting and it was good to meet you although briefly.
Tom D’Ambra, Chairman & CEO, AMRI
Congratulations on another successful USA-India Chamber of Commerce event. I enjoyed seeing you again, and really appreciated the networking opportunities you facilitated. Thank you for involving me and AMRI in the event.
Suri Venkatachalam, PhD, CEO & Managing Director, Connexios Life Sciences
Congratulations once again for organizing such a wonderful event. Many thanks for inviting me. I truly enjoyed the event.
Jeff Elton, Chairman, KEW Group
I had fun and benefitted from the meeting as always
Sidhant, Founder & CEO, Sana Care (Startup Company)
Thanks for inviting me to the conference. It was amazing with great panels and people. I met Amar, Kiran and Dr. Bhan and will follow-up with them. Hopefully, things will work out.
Ira M. Herman, PhD, Professor and Director, Tufts University School of Medicine
Congratulations on a wonderful day.. on every level!! I look forward to our continued workings together...
Grannum R. Sant, MD,FRCS,FACS; Vice President, Genzyme
Outstanding meeting yesterday and congratulations on your organization and execution! All your hard work and planning bore fruit.
Thanks again for extending the invitation to me – I learnt a lot and also had an opportunity to network with the movers and shakers (both US and India).
Bill Chin did an excellent job as emcee and all the panel discussions were informative, cutting-edge and relevant.
Dr. Mehul Mehta, Chief Strategy Officer, Partners Harvard Medical International
I want to compliment you on a really terrific & high-caliber meeting. Thank you for inviting me. The level of the discussions was superb and the organization was superb.
L J Botticelli, PhD; Chief Business Officer, School of Medicine & University Advancement, Tufts University
I write to congratulate you on a highly successful Summit. To be sure, I found it most productive and of particular value to our efforts at the Tufts Institute for Biopharmaceutical Partnerships.
Too, thank you very much for the opportunity to actively participate in the Industry-Academic Partnership Strategy Session. I enjoyed the discussion and appreciated the varied perspectives to forming innovative global partnerships. Moreover, it confirmed - straightaway - the Tufts strategy to engage proactively in our 'pharma arbitrage' approach. The networking which followed was beneficial. Again, many thanks. I look forward to participating again, next year.
Sourav Basu,
Vice President, TCG Life Sciences
I am attending the meeting for past 3 years now and see a high value in this wonderful summit. Looking forward to the next summit.
R.K. Suri, Chief Executive- Biologicals, Panacea Biotec
At the outset I must thank you for organizing such an eventful meeting of this scale and ensuring presence of who’s who in Boston. Both Sumit Jain and myself are highly appreciative of the personal care taken by you for this mammoth task. High quality meeting indeed!
From Mass Pike: Take exit 18 - Allston / Cambridge (left hand exit).
